{{Rsnum
|rsid=8101143
|Chromosome=19
|position=21956136
|Orientation=plus
|GMAF=0.1846
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 51.3 | 40.7 | 8.0
| HCB | 90.5 | 9.5 | 0.0
| JPT | 85.8 | 14.2 | 0.0
| YRI | 50.3 | 39.3 | 10.3
| ASW | 51.8 | 44.6 | 3.6
| CHB | 90.5 | 9.5 | 0.0
| CHD | 81.7 | 18.3 | 0.0
| GIH | 67.0 | 30.0 | 3.0
| LWK | 56.0 | 33.0 | 11.0
| MEX | 69.0 | 29.3 | 1.7
| MKK | 52.3 | 37.4 | 10.3
| TSI | 71.6 | 23.5 | 4.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22864933
  |Trait=Capecitabine sensitivity
  |Title=Identification of novel germline polymorphisms governing capecitabine sensitivity.
  |RiskAllele=
  |Pval=2E-7
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}